학술논문
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial
Document Type
Article
Author
Jabbour, Elias ; Short, Nicholas J; Senapati, Jayastu; Jain, Nitin; Huang, Xuelin; Daver, Naval; DiNardo, Courtney D; Pemmaraju, Naveen; Wierda, William; Garcia-Manero, Guillermo; Montalban Bravo, Guillermo; Sasaki, Koji; Kadia, Tapan M; Khoury, Joseph; Wang, Sa A; Haddad, Fadi G; Jacob, Jovitta; Garris, Rebecca; Ravandi, Farhad; Kantarjian, Hagop M
Source
In The Lancet Haematology June 2023 10(6):e433-e444
Subject
Language
ISSN
2352-3026